Laura Diluvio Selected Research

Piroxicam (Feldene)

1/2019	Monitoring treatment response in patients affected by actinic keratosis: Dermoscopic assessment and metalloproteinases evaluation after piroxicam 0.8% and sunfilter cream.
10/2018	Current developments in pharmacotherapy for actinic keratosis.
1/2018	Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study.
9/2017	Treatment of Multiple Actinic Keratosis and Field of Cancerization with Topical Piroxicam 0.8% and Sunscreen 50+ in Organ Transplant Recipients: A Series of 10 Cases.
1/2017	Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
1/2016	Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study.
1/2015	The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors.
1/2010	Topical treatment of actinic keratoses with piroxicam 1% gel: a preliminary open-label study utilizing a new clinical score.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Diluvio Research Topics

Disease

14	Actinic Keratosis 08/2022 - 01/2009
11	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2022 - 06/2006
7	Inflammation (Inflammations) 05/2022 - 06/2006
6	Skin Neoplasms (Skin Cancer) 09/2017 - 01/2010
5	Neoplasms (Cancer) 01/2019 - 01/2015
4	Urticaria (Hives) 01/2022 - 01/2019
4	Chronic Urticaria 01/2022 - 01/2019
4	Basal Cell Carcinoma (Rodent Ulcer) 01/2019 - 01/2009
3	Pain (Aches) 05/2022 - 04/2014
3	Psoriatic Arthritis 12/2020 - 01/2009
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 01/2018
3	Carcinogenesis 10/2018 - 01/2010
2	Atrophy 11/2020 - 09/2018
2	Atopic Dermatitis (Atopic Eczema) 02/2019 - 01/2008
2	Melanoma (Melanoma, Malignant) 01/2016 - 01/2015
2	Hyperplasia 05/2011 - 09/2009
1	Seborrheic Keratosis 05/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Alopecia Areata 11/2020
1	Nervous System Diseases (Neurological Disorders) 11/2020
1	Solar Urticaria 09/2020
1	Vitiligo 01/2020
1	Hepatitis B 01/2020
1	Eczema 02/2019
1	Dermatitis 02/2019
1	Seborrheic Dermatitis 01/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Acrodermatitis (Gianotti Crosti Syndrome) 01/2019
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Pruritus (Itching) 09/2018
1	Vulvar Lichen Sclerosus 09/2018
1	Constipation 09/2018
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 09/2018
1	Hodgkin Disease (Hodgkin's Disease) 03/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Carcinoma (Carcinomatosis) 01/2015

Drug/Important Bio-Agent (IBA)

8	Piroxicam (Feldene)FDA LinkGeneric 01/2019 - 01/2010
5	Pharmaceutical PreparationsIBA 08/2022 - 01/2009
5	Omalizumab (Xolair)FDA Link 01/2022 - 01/2019
5	Imiquimod (Aldara)FDA LinkGeneric 01/2020 - 03/2008
4	CytokinesIBA 05/2022 - 09/2009
4	Sunscreening Agents (Sunscreens)IBA 01/2018 - 01/2016
4	EnzymesIBA 09/2017 - 01/2010
3	Monoclonal AntibodiesIBA 05/2022 - 01/2019
3	Interleukin-17 (Interleukin 17)IBA 05/2022 - 05/2011
2	SolutionsIBA 08/2022 - 01/2019
2	Fluorouracil (Carac)FDA LinkGeneric 08/2022 - 01/2019
2	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 08/2022 - 01/2019
2	Interleukin-23 (Interleukin 23)IBA 05/2022 - 01/2022
2	Adalimumab (Humira)FDA Link 05/2022 - 12/2020
2	Biological ProductsIBA 01/2022 - 12/2020
2	Hyaluronic Acid (Hyaluronan)IBA 11/2020 - 01/2019
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2019
2	Metalloproteases (Metalloproteinases)IBA 01/2019 - 01/2015
2	ProstaglandinsIBA 10/2018 - 01/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2018 - 11/2009
2	3-ingenyl angelateIBA 01/2017 - 01/2016
2	Rituximab (Mabthera)FDA Link 03/2016 - 11/2009
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2016 - 01/2010
2	tazarotene (Tazorac)FDA Link 01/2015 - 05/2007
2	interleukin-21 (interleukin 21)IBA 05/2011 - 09/2009
2	pimecrolimus (Elidel)FDA Link 06/2010 - 01/2008
1	salicylic acid drug combination 5-fluorouracilIBA 08/2022
1	Urea (Carbamide)FDA LinkGeneric 05/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2022
1	Hydroxy AcidsIBA 05/2022
1	Advanced Glycation End ProductsIBA 05/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	tildrakizumabIBA 01/2022
1	SteroidsIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 08/2020
1	Dimethyl FumarateIBA 01/2020
1	InterleukinsIBA 01/2020
1	EmollientsIBA 02/2019
1	Immunoglobulin A (IgA)IBA 02/2019
1	Histamine Antagonists (Antihistamines)IBA 01/2019
1	anti-IgE antibodiesIBA 01/2019
1	glutathione-C4IBA 01/2019
1	Phosphodiesterase 4 InhibitorsIBA 01/2019
1	apremilastIBA 01/2019
1	Investigational DrugsIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Diclofenac (SR 38)FDA LinkGeneric 10/2018
1	Ointments (Pastes)IBA 09/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 09/2018
1	ThiazidesIBA 01/2018
1	DiureticsIBA 01/2018
1	Cyclooxygenase 1IBA 09/2017
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Epidermal Growth Factor (EGF)IBA 01/2015
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2015

Therapy/Procedure

10	Therapeutics 05/2022 - 01/2009
2	Drug Therapy (Chemotherapy) 10/2018 - 03/2016
2	Chemoprevention 01/2015 - 01/2010
1	Biological Therapy 05/2022
1	Subcutaneous Injections 05/2022
1	Aftercare (After-Treatment) 03/2016